NKGen Biotech to Present on Troculeucel for Neurodegenerative Diseases at 4th Great Bay Cell and Gene Therapy Forum
NKGen Biotech Inc NKGN
$0.01
▲ +0.00%
(+$0.00)
Open
$0.01
Prev Close
$0.01
Day Range
$0.01 – $0.01
52W Range
$0.00 – $0.33
Market Cap
$1.57M
Beta
0.72
EPS (TTM)
$-1.09
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | OTC MARKETS |
| Currency | USD |
| IPO Date | 2021-05-21 |
| Shares Out. | 130,600,000 |
| Website | nkgenbiotech.com/ ↗ |
| Phone | 13026365400 |
NKGen Biotech Inc is a publicly traded company under the ticker symbol NKGN on the OTC MARKETS, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.